Nearly 600,000 defective asthma inhalers pulled from U.S. market after consumers complained

PHOTO CREDIT ALLISPOSSIBLE.ORG.UK FLICKR

A major British drugmaker is recalling more than 593,000 asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers after receiving a number of complaints about leakage and packaging.

GSK Plc said there are concerns that the Ventolin asthma inhaler may deliver fewer doses of the medicine than indicated, Reuters reported.

The defect does not pose an immediate danger to patients, so consumers are not being instructed to return already purchased inhalers.

The U.S. Food and Drug Administration (FDA) approved the recall, Reuters reported.

JOIN THE CONVERSATION....